APREA THERAPEUTICS, INC. (APRE) Social Stream
APREA THERAPEUTICS INC (APRE) Price Targets From Analysts
The tables below show the price targets and recommendations analysts covering APRE.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-09 | 3 | $5 | $4 | $4.5 | $5.73 | -21.47% |
| 2022-03-16 | 3 | $5 | $2 | $3.5 | $5.73 | -38.92% |
| 2022-07-08 | 3 | $5 | $2 | $3.333 | $5.73 | -41.83% |
| 2022-08-15 | 3 | $3 | $2 | $2.5 | $5.73 | -56.37% |
| 2022-11-10 | 3 | $60 | $60 | $60 | $5.73 | 947.12% |
| 2023-03-17 | 3 | $60 | $16 | $45.333 | $5.73 | 691.15% |
| 2023-03-31 | 3 | $60 | $16 | $32 | $5.73 | 458.46% |
| 2023-11-10 | 3 | $20 | $9 | $15 | $5.73 | 161.78% |
The Trend in the Analyst Price Target
Over the past 29 months, APRE's average price target has gone up $7.75.
Over the past 35 weeks, APRE's average upside potential has been 420.41%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2023-03-10 | 3 | 60 | 16 | 45.333 | 5.040 | 799.46% |
| 2023-03-31 | 3 | 60 | 16 | 32.000 | 4.440 | 620.72% |
| 2023-05-16 | 3 | 20 | 9 | 15.000 | 3.887 | 285.9% |
| 2023-10-16 | 3 | 20 | 9 | 15.000 | 5.200 | 188.46% |
| 2023-11-10 | 3 | 20 | 9 | 15.000 | 3.840 | 290.62% |
APRE Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1 | 3 | 0 | 0 | 0 | 0 | 3 |
The Trend in the Broker Recommendations
APRE's average broker recommendation rating improved by 0 over the prior 31 weeks.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- APREA THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is higher than 586.18% of all US stocks.
- APREA THERAPEUTICS INC's number of analysts covering the stock is greater than 111.02% of all US stocks.
- In terms of how APREA THERAPEUTICS INC fares relative to stocks in the small market cap category, note that its average analyst price target is greater than 491.24% of that group.
- To contextualize these metrics, consider that out of Healthcare stocks, APREA THERAPEUTICS INC's variance in analysts' estimates is lower than -490.66% of them.
Stocks similar to APREA THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are MIRM, FULC, and BCEL.
View All Top Stocks by Price Target
Is APRE a Buy, Hold or Sell? See the POWR Ratings now!